Bionic Biologics represent a novel therapeutic modality that integrates principles of biologic and synthetic design. This innovative platform enables the targeting of well-validated yet previously ...
Research has repeatedly shown that high school dual enrollment correlates with higher rates of college attendance and graduation. But it’s unclear how different ways of delivering such courses—online ...
Exercise is guideline-recommended for patients with osteoarthritis of the knee, although comparative benefits from specific forms of exercise are less certain. This literature review and meta-analysis ...
A significant portion of disease-relevant proteins remain “undruggable” by traditional therapeutic approaches, representing a major hurdle in drug discovery. Targeted protein degradation (TPD) is ...
Finally, some good news: More and more people are getting active, according to the Sports and Fitness Industry Association’s (SFIA) recent report. For the first time since they started tracking ...
The uncertainty around the future of Elevidys hasn’t destroyed Roche’s belief in the potential of gene therapies, the Swiss company’s head of pharma has told Fierce Biotech, as the pharma continues to ...
Abstract: The paper introduces a predicate version of two-layered fuzzy probability logic, extending the known propositional probability logic based on the infinite-valued logic of Lukasiewicz. The ...
A novel integrated molecular imaging approach enables precise localization and quantification of heart damage, as well as accurate identification of disease subtypes. The dual PET/MR and PET/CMR ...
Dipti Mehta has worked as a Senior Application Scientist at Revvity since 2022. Her research in DNA and protein assay development with LabChip GX Touch technology has generated new commercial assays.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback